Company news
Aethlon Medical, Inc. news in 2025
Aethlon Medical, Inc.'s news releases, calls and decks from 2025, newest first.
Aethlon Medical Announces Pricing of a Private Placement and Warrant Inducement, Priced At-The-Market for Aggregate Gross Proceeds of $3.3 Million
December 5, 2025
Aethlon Medical Announces Publication of Preclinical Data Showing That the GNA Affinity Resin in the Hemopurifier® Binds to Extracellular Vesicles in Long COVID patient samples and Decreases Inflammatory microRNAs
December 2, 2025
Aethlon Medical Announces Fiscal Q2 2025 Financial Results and Corporate Update
November 12, 2025
Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 12, 2025
November 7, 2025
Aethlon Medical's Hemopurifier® shows Changes in Extracellular Vesicles, Extracellular MicroRNAs, and T Cell Numbers in Australian Oncology Clinical Trial
October 7, 2025
Aethlon Medical Announces Pricing of $4.5 Million Public Offering
September 4, 2025
Aethlon Medical Announces Issuance of Hemopurifier® Patents for the Treatment of Long COVID and COVID-19-associated Coagulopathy (CAC)
September 3, 2025
Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2025, and Provides Corporate Update
August 13, 2025
Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 13, 2025
August 5, 2025
Aethlon Medical, Inc. Announces Positive Data Safety Monitoring Board Review and Recommendation to Advance to Next Clinical Trial Cohort
July 15, 2025
Aethlon Medical Announces Financial Results for the Fiscal Fourth Quarter Ended March 31, 2025, and Provides Corporate Update
June 26, 2025
Aethlon Medical to Release Fiscal Fourth Quarter Financial Results and Host Conference Call on June 26, 2025
June 20, 2025
Aethlon Medical Treats Second Patient in Australian Hemopurifier(R) Cancer Trial
June 19, 2025
Aethlon Medical Treats Second Patient in Australian Hemopurifier® Cancer Trial
June 18, 2025
Presenting on Emerging Growth Conference 83 Day 1 on June 17; Register to live stream
June 16, 2025
Aethlon Medical to Present New Pre-Clinical Data at the Keystone Symposium on Long COVID and Other Post-Acute Infection Syndromes
June 9, 2025
Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Platelet-Derived Extracellular Vesicles from Plasma
May 14, 2025
Aethlon Medical Publishes Preclinical Data on the Hemopurifier® in Transplant Immunology Journal
March 10, 2025
Aethlon Medical to Present at the Emerging Growth Conference on February 19, 2025
February 12, 2025
Aethlon Medical Announces Financial Results for the Fiscal Third Quarter Ended December 31, 2024 and Provides Corporate Update
February 11, 2025
Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2025
February 4, 2025
Aethlon Medical Treats First Patient in Australian Hemopurifier® Cancer Trial
January 28, 2025
Calls in 2025
Decks in 2025
- Investor Presentation (August 2025)
Investor deck · 21 slides · Aug 21, 2025
- Investor Presentation (February 2025)
Investor deck · 20 slides · February 2025